[en] Essential thrombocythemia is a myeloproliferative disorder affecting megakaryocyte and is characterized by frequent thrombotic or hemorrhagic complications. In young patients, the optimal management of thrombocythaemia is controversial. Since th relationship of thrombosis and hemorrhage to platelet counts is not demonstrated, ther is no clear inidcation for using drugs capable of lowering platelet counts in young asymptomatic subjects. However, treatment should be offered to patients with a definite high risk of major or life-threatening hemostatic complications. The present paper reviews the incidence and risk factors for thrombotic complications and the use of medications inhibiting platelet production.
Cortelazzo S, Viero P, Finazzi G. Incidence and risk factors for thrombotic complications in historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990 ; 8 : 556-62.
Beutler E, Lichtman M, Coller B. Williams Hematology, Fifth edition. New York: McGraw-Hill, 1995 : 340-4.
Hehlmann R, John M, Baumann B, Köpeke W. Essential thrombocythemia. Clinical characteristics and course of 61 cases. Cancer 1988 ; 61 : 2487-94.
Murphy S, Iland H, Rosenthal D, Laszlo J. Essential thombocythemia : An interim report from the Polycythemia Vera Study Group. Semin Hematol 1986 ; 23 : 177-82.
Cortelazzo S, Finazzi G, Ruggeri M. Hydroxyurea for patients with essential thrombocythemia and high risk of thrombosis. N Engl J Med 1995 ; 332 : 1132-6.
MacIntyre K, Hoagland H, Silverstein M, Petitt R. Essential thrombocythemia in young adults. Mayo Clin Proc 1991 ; 66 : 149-54.
Giles F, Singer C, Gray A, et al. Alpha-interferon therapy for essential thrombocythaemia. Lancet 1988 ; 2 : 70-6.
Gisslinger H, Chott A, Scheithauer H, et al : Interferon in essential thrombocythaemia. Br J Haematol 1991 ; 79 (Suppl. 1) : 42-8.
Silverstein M, Petitt R, Solberg L, et al. (Anagrelide Study Group). Anagrelide, a therapy for thrombocythemic states : Experience in 577 patients. Am J Med 1992 ; 92 : 69-76.
Alving B, Coller B, Duffy T, et al. Platelets : Pharmacologic and transfusion strategies to alter function and production. ASH educational program, 37th meeting of the American Society of hematology, Seattle, december 2-5, 1995.
